In reliability engineering, few indicators are as consistently revealing as the particles that infiltrate a lubrication system. Long before vibration, temperature, or performance changes become ...

In the U.S. there are more than 150 million emergency department (ED) visits each year, and the number is expected to rise. ED physicians face enormous pressure to quickly and correctly diagnose ...

The US Department of Health and Human Services (HHS) said it will continue to fund a Lyme disease project that aims to accelerate development of diagnostics for tick-borne diseases. Secretary Robert F ...

Actron OBD II scan tool review shows functionality for vehicle diagnostics. Woman checks Bernese mountain dog's fur, sees something moving with a tail After winning his first Oscar, Tom Cruise kept ...

Natera said it has acquired Foresight Diagnostics in a deal valued at up to $450 million, bolstering the company's portfolio of minimal residual disease, or MRD, testing products. The genetic testing ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cleveland Diagnostics is ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

In this episode of The Top Line, Fierce’s Chris Hayden speaks with Foresight Diagnostics co-founders Dr. Jake Chabon and Dr. Max Diehn about how their company is delivering the next generation of ...

The company hopes to develop specialized AIs that perform at a superhuman level in specific fields without posing existential risks. Share on Facebook (opens in a new window) Share on X (opens in a ...

Archimed has carved out Ark Diagnostics from Soulbrain, PE Hub can reveal. The healthcare investor sees plenty of opportunity in the diagnostics sector, Vincent Guillaumot, managing partner, told PE ...